MedTrace Logo

CGM Experience, Preferences & Blood Glucose Parameters

NCT07607015 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-05-26

No results posted yet for this study

Summary

This is an open-label, prospective, multicenter observational study designed to evaluate the perceived benefits, device experience, preference, and glucose-related parameters associated with the Instara-1 Continuous Glucose Monitoring device. The study will include patients with diabetes and healthcare professionals. Patients will use Instara- 1 and will be followed up to assess device experience, glucose parameters, and diabetes-related quality of life. Healthcare professionals will evaluate device experience and preference, including comparison with FreeStyle Libre 2.

Conditions

  • Diabete Mellitus
  • Type2diabetes
  • type1diabetes
  • Gestational Diabetes
  • Pre Diabetes

Interventions

DEVICE

CGM

Comparison of 2 devices by HCP

Sponsors & Collaborators

  • Peshawar General Hospital

    collaborator OTHER

  • Getz Pharma

    lead INDUSTRY

Principal Investigators

  • Jahanzeb Kamal Khan, MCPS · CPSP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-10
Primary Completion
2027-08-10
Completion
2027-08-10
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07607015 on ClinicalTrials.gov